This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Aetiology

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Low dose radiation may be an important factor as many cases have been reported 10-30 years after X-ray exposure.

  • radioiodine - there is evidence that individuals treated with radioiodine have a small but significant increase in the incidence of thyroid cancer (1).
  • a history of radiation exposure to the neck area is associated with increased risk of thyroid cancer, often after a delay of well over a decade; some cases can be traced to radiation treatment in childhood (2)

Both deficiency and excess dietary iodine are associated with increased risk of thyroid cancer (2)

Other predisposing factors include (2):

  • prolonged stimulation with thyroid stimulating hormone (which can be due to chronic iodine deficiency)
  • chronic lymphocytic thyroiditis (lymphoma)
  • genetic factors (linked with medullary thyroid cancer)
  • women are more than twice as likely as men to develop thyroid cancer

Reference:

  1. Franklyn JA, Maisonneuve P, Sheppard MC et al (1999). Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet; 338 (11): 712-718.
  2. NICE (November 2004). Improving outcomes in head and neck cancers - The Manual

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.